
Anna Kathy Aman
Examiner (ID: 4131, Phone: (571)272-4515 , Office: P/2914 )
| Most Active Art Unit | 2914 |
| Art Unit(s) | 2914, 2973 |
| Total Applications | 3318 |
| Issued Applications | 3250 |
| Pending Applications | 16 |
| Abandoned Applications | 54 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 1532114
[patent_doc_number] => 06410315
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-06-25
[patent_title] => 'Genes encoding polypeptides containing signal sequences'
[patent_app_type] => B1
[patent_app_number] => 09/436183
[patent_app_country] => US
[patent_app_date] => 1999-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 8691
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/410/06410315.pdf
[firstpage_image] =>[orig_patent_app_number] => 09436183
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/436183 | Genes encoding polypeptides containing signal sequences | Nov 7, 1999 | Issued |
| 09/434196 | COMPOSITIONS AND METHODS USING EUKARYOTIC RAD52 | Nov 3, 1999 | Abandoned |
Array
(
[id] => 4367801
[patent_doc_number] => 06287857
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-11
[patent_title] => 'Nucleic acid delivery vehicles'
[patent_app_type] => 1
[patent_app_number] => 9/426680
[patent_app_country] => US
[patent_app_date] => 1999-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 33
[patent_no_of_words] => 28505
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/287/06287857.pdf
[firstpage_image] =>[orig_patent_app_number] => 426680
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/426680 | Nucleic acid delivery vehicles | Oct 24, 1999 | Issued |
Array
(
[id] => 1380550
[patent_doc_number] => 06551811
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-04-22
[patent_title] => 'Method for sorting antifungal molecules acting on the glucanosyltransferase activity'
[patent_app_type] => B1
[patent_app_number] => 09/242913
[patent_app_country] => US
[patent_app_date] => 1999-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 14
[patent_no_of_words] => 16255
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/551/06551811.pdf
[firstpage_image] =>[orig_patent_app_number] => 09242913
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/242913 | Method for sorting antifungal molecules acting on the glucanosyltransferase activity | Oct 12, 1999 | Issued |
Array
(
[id] => 4355942
[patent_doc_number] => 06291660
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-18
[patent_title] => 'Fungal genes required for normal growth and development'
[patent_app_type] => 1
[patent_app_number] => 9/415522
[patent_app_country] => US
[patent_app_date] => 1999-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21058
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/291/06291660.pdf
[firstpage_image] =>[orig_patent_app_number] => 415522
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/415522 | Fungal genes required for normal growth and development | Oct 7, 1999 | Issued |
| 09/414671 | DNA VACCINE FORMULATIONS | Oct 6, 1999 | Abandoned |
Array
(
[id] => 4257295
[patent_doc_number] => 06258565
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-10
[patent_title] => 'Expression vectors based on RK2 and TOL plasmids'
[patent_app_type] => 1
[patent_app_number] => 9/242945
[patent_app_country] => US
[patent_app_date] => 1999-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 16
[patent_no_of_words] => 13434
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/258/06258565.pdf
[firstpage_image] =>[orig_patent_app_number] => 242945
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/242945 | Expression vectors based on RK2 and TOL plasmids | Sep 9, 1999 | Issued |
Array
(
[id] => 4256203
[patent_doc_number] => 06203991
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-03-20
[patent_title] => 'Inhibition of smooth muscle cell migration by heme oxygenase I'
[patent_app_type] => 1
[patent_app_number] => 9/378528
[patent_app_country] => US
[patent_app_date] => 1999-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13608
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/203/06203991.pdf
[firstpage_image] =>[orig_patent_app_number] => 378528
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/378528 | Inhibition of smooth muscle cell migration by heme oxygenase I | Aug 19, 1999 | Issued |
Array
(
[id] => 4269466
[patent_doc_number] => 06322982
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-27
[patent_title] => 'Modulation of drug resistance via ubiquitin carboxy-terminal hydrolase'
[patent_app_type] => 1
[patent_app_number] => 9/365405
[patent_app_country] => US
[patent_app_date] => 1999-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9894
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/322/06322982.pdf
[firstpage_image] =>[orig_patent_app_number] => 365405
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/365405 | Modulation of drug resistance via ubiquitin carboxy-terminal hydrolase | Aug 1, 1999 | Issued |
Array
(
[id] => 1494008
[patent_doc_number] => 06342375
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-01-29
[patent_title] => 'Modified methylotrophic Pichia pastoris yeast which secretes human growth hormone'
[patent_app_type] => B1
[patent_app_number] => 09/284878
[patent_app_country] => US
[patent_app_date] => 1999-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 11016
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 173
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/342/06342375.pdf
[firstpage_image] =>[orig_patent_app_number] => 09284878
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/284878 | Modified methylotrophic Pichia pastoris yeast which secretes human growth hormone | Jul 20, 1999 | Issued |
Array
(
[id] => 1238564
[patent_doc_number] => 06685935
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-02-03
[patent_title] => 'Vectors for the diagnosis and treatment of solid tumors including melanoma'
[patent_app_type] => B1
[patent_app_number] => 09/358052
[patent_app_country] => US
[patent_app_date] => 1999-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 46
[patent_no_of_words] => 40156
[patent_no_of_claims] => 188
[patent_no_of_ind_claims] => 33
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/685/06685935.pdf
[firstpage_image] =>[orig_patent_app_number] => 09358052
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/358052 | Vectors for the diagnosis and treatment of solid tumors including melanoma | Jul 20, 1999 | Issued |
Array
(
[id] => 4366426
[patent_doc_number] => 06287775
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-11
[patent_title] => 'Early detection of ovarian carcinoma using p16 gene products'
[patent_app_type] => 1
[patent_app_number] => 9/346200
[patent_app_country] => US
[patent_app_date] => 1999-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4447
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/287/06287775.pdf
[firstpage_image] =>[orig_patent_app_number] => 346200
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/346200 | Early detection of ovarian carcinoma using p16 gene products | Jun 30, 1999 | Issued |
Array
(
[id] => 4355416
[patent_doc_number] => 06218359
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-17
[patent_title] => 'Screening method using the RZR receptor family'
[patent_app_type] => 1
[patent_app_number] => 9/342479
[patent_app_country] => US
[patent_app_date] => 1999-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4308
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 341
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/218/06218359.pdf
[firstpage_image] =>[orig_patent_app_number] => 342479
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/342479 | Screening method using the RZR receptor family | Jun 28, 1999 | Issued |
| 09/336655 | METHOD AND DEVICE FOR MICROINJECTION OF MACROMOLECULES INTO NON-ADHERENT CELLS | Jun 17, 1999 | Abandoned |
Array
(
[id] => 6468653
[patent_doc_number] => 20020151058
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-17
[patent_title] => 'VECTOR CONSTRUCTION BY HOST CELL-MEDIATED RECOMBINATION'
[patent_app_type] => new
[patent_app_number] => 09/336421
[patent_app_country] => US
[patent_app_date] => 1999-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7933
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0151/20020151058.pdf
[firstpage_image] =>[orig_patent_app_number] => 09336421
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/336421 | VECTOR CONSTRUCTION BY HOST CELL-MEDIATED RECOMBINATION | Jun 16, 1999 | Abandoned |
Array
(
[id] => 4138613
[patent_doc_number] => 06060316
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-05-09
[patent_title] => 'Methods of targeting of viral entry'
[patent_app_type] => 1
[patent_app_number] => 9/327841
[patent_app_country] => US
[patent_app_date] => 1999-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5840
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/060/06060316.pdf
[firstpage_image] =>[orig_patent_app_number] => 327841
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/327841 | Methods of targeting of viral entry | Jun 7, 1999 | Issued |
Array
(
[id] => 4233746
[patent_doc_number] => 06165754
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-12-26
[patent_title] => 'Method of expressing an exogenous nucleic acid'
[patent_app_type] => 1
[patent_app_number] => 9/328020
[patent_app_country] => US
[patent_app_date] => 1999-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 6572
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/165/06165754.pdf
[firstpage_image] =>[orig_patent_app_number] => 328020
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/328020 | Method of expressing an exogenous nucleic acid | Jun 7, 1999 | Issued |
Array
(
[id] => 4418979
[patent_doc_number] => 06225063
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-01
[patent_title] => 'RNA channels in biological membranes'
[patent_app_type] => 1
[patent_app_number] => 9/315886
[patent_app_country] => US
[patent_app_date] => 1999-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 17814
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/225/06225063.pdf
[firstpage_image] =>[orig_patent_app_number] => 315886
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/315886 | RNA channels in biological membranes | May 19, 1999 | Issued |
Array
(
[id] => 1449730
[patent_doc_number] => 06455299
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-24
[patent_title] => 'Methods of use of viral vectors to deliver antigen to dendritic cells'
[patent_app_type] => B1
[patent_app_number] => 09/310560
[patent_app_country] => US
[patent_app_date] => 1999-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 35
[patent_no_of_words] => 15759
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/455/06455299.pdf
[firstpage_image] =>[orig_patent_app_number] => 09310560
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/310560 | Methods of use of viral vectors to deliver antigen to dendritic cells | May 11, 1999 | Issued |
Array
(
[id] => 4101797
[patent_doc_number] => 06051430
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-04-18
[patent_title] => 'Vectors and methods for providing cells with additional nucleic acid material integrated in the genome of said cells'
[patent_app_type] => 1
[patent_app_number] => 9/317062
[patent_app_country] => US
[patent_app_date] => 1999-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10084
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/051/06051430.pdf
[firstpage_image] =>[orig_patent_app_number] => 317062
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/317062 | Vectors and methods for providing cells with additional nucleic acid material integrated in the genome of said cells | May 6, 1999 | Issued |